157 related articles for article (PubMed ID: 31775247)
1. Benzo[
Kim YJ; Lee DH; Choi YS; Jeong JH; Kwon SH
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775247
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Benzimidazole Pyrazolone Scaffold That Inhibits KDM4 Lysine Demethylases and Reduces Proliferation of Prostate Cancer Cells.
Carter DM; Specker E; Przygodda J; Neuenschwander M; von Kries JP; Heinemann U; Nazaré M; Gohlke U
SLAS Discov; 2017 Aug; 22(7):801-812. PubMed ID: 28346812
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity.
Lee HJ; Kim BK; Yoon KB; Kim YC; Han SY
Invest New Drugs; 2017 Dec; 35(6):733-741. PubMed ID: 28905188
[TBL] [Abstract][Full Text] [Related]
4. Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.
Rotili D; Tomassi S; Conte M; Benedetti R; Tortorici M; Ciossani G; Valente S; Marrocco B; Labella D; Novellino E; Mattevi A; Altucci L; Tumber A; Yapp C; King ON; Hopkinson RJ; Kawamura A; Schofield CJ; Mai A
J Med Chem; 2014 Jan; 57(1):42-55. PubMed ID: 24325601
[TBL] [Abstract][Full Text] [Related]
5. An analog of BIX-01294 selectively inhibits a family of histone H3 lysine 9 Jumonji demethylases.
Upadhyay AK; Rotili D; Han JW; Hu R; Chang Y; Labella D; Zhang X; Yoon YS; Mai A; Cheng X
J Mol Biol; 2012 Feb; 416(3):319-27. PubMed ID: 22227394
[TBL] [Abstract][Full Text] [Related]
6. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
[TBL] [Abstract][Full Text] [Related]
7. Lysine-241 Has a Role in Coupling 2OG Turnover with Substrate Oxidation During KDM4-Catalysed Histone Demethylation.
Hancock RL; Abboud MI; Smart TJ; Flashman E; Kawamura A; Schofield CJ; Hopkinson RJ
Chembiochem; 2018 May; 19(9):917-921. PubMed ID: 29443450
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterisation of Substrate-Based Peptides as Inhibitors of Histone Demethylase KDM4C.
Nielsen SD; Leurs U; Bergner M; Barris SA; Devkota K; Meyer K; Iaria D; McCaughan J; Lohse B; Kristensen JL; Clausen RP
Protein Pept Lett; 2016; 23(9):772-6. PubMed ID: 27295953
[TBL] [Abstract][Full Text] [Related]
9. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Diallo H; Douault C; Drewes G; Eagle R; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Liddle J; Mosley J; Muelbaier M; Randle R; Rioja I; Rueger A; Seal GA; Sheppard RJ; Singh O; Taylor J; Thomas P; Thomson D; Wilson DM; Lee K; Prinjha RK
J Med Chem; 2016 Feb; 59(4):1357-69. PubMed ID: 26771107
[TBL] [Abstract][Full Text] [Related]
10. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
Chin YW; Han SY
Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
[TBL] [Abstract][Full Text] [Related]
11. KDM4 Demethylases: Structure, Function, and Inhibitors.
Jiang Y; Liu L; Yang ZQ
Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
[TBL] [Abstract][Full Text] [Related]
12. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.
King ON; Li XS; Sakurai M; Kawamura A; Rose NR; Ng SS; Quinn AM; Rai G; Mott BT; Beswick P; Klose RJ; Oppermann U; Jadhav A; Heightman TD; Maloney DJ; Schofield CJ; Simeonov A
PLoS One; 2010 Nov; 5(11):e15535. PubMed ID: 21124847
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).
Leurs U; Clausen RP; Kristensen JL; Lohse B
Bioorg Med Chem Lett; 2012 Sep; 22(18):5811-3. PubMed ID: 22917519
[TBL] [Abstract][Full Text] [Related]
14. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Drewes G; Eagle R; Garton N; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Pemberton M; Rioja I; Seal GA; Shipley T; Singh O; Suckling CJ; Taylor J; Thomas P; Wilson DM; Lee K; Prinjha RK
J Med Chem; 2016 Feb; 59(4):1370-87. PubMed ID: 26771203
[TBL] [Abstract][Full Text] [Related]
15. Unravelling KDM4 histone demethylase inhibitors for cancer therapy.
Baby S; Gurukkala Valapil D; Shankaraiah N
Drug Discov Today; 2021 Aug; 26(8):1841-1856. PubMed ID: 34051367
[TBL] [Abstract][Full Text] [Related]
16. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
Berry WL; Janknecht R
Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design and discovery of potent and selective KDM5 inhibitors.
Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
[TBL] [Abstract][Full Text] [Related]
18. Advances in histone demethylase KDM4 as cancer therapeutic targets.
Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH
FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances with KDM4 Inhibitors and Potential Applications.
Wu Q; Young B; Wang Y; Davidoff AM; Rankovic Z; Yang J
J Med Chem; 2022 Jul; 65(14):9564-9579. PubMed ID: 35838529
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.
Gerken PA; Wolstenhulme JR; Tumber A; Hatch SB; Zhang Y; Müller S; Chandler SA; Mair B; Li F; Nijman SMB; Konietzny R; Szommer T; Yapp C; Fedorov O; Benesch JLP; Vedadi M; Kessler BM; Kawamura A; Brennan PE; Smith MD
Angew Chem Int Ed Engl; 2017 Dec; 56(49):15555-15559. PubMed ID: 28976073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
